Veterinary Medicines

Kaltetan, 250 mg/ml + 80 mg/ml + 10 mg/ml solution for infusion for horses, cattle and pigs

Authorised
  • Sodium glycerophosphate pentahydrate
  • Magnesium chloride hexahydrate
  • CALCIUM GLUCONATE FOR INJECTION
Download as PDF

Identifikacija proizvoda

Naziv VMP-a:
Kaltetan, 250 mg/ml + 80 mg/ml + 10 mg/ml solution for infusion for horses, cattle and pigs
Kaltetan 250 mg/ml + 80 mg/ml + 10 mg/1 ml Roztwór do infuzji
Djelatna tvar:
Ciljne vrste životinja:
Način primjene:
  • Intravenski

Pojedinosti o proizvodu

Djelatna tvar i jačina:
  • Dostupno samo u English
    10.00
    miligram
    /
    1.00
    mililitar
  • Dostupno samo u English
    80.00
    miligram
    /
    1.00
    mililitar
  • Dostupno samo u English
    250.00
    miligram/mililitar
    /
    1.00
    miligram/mililitar
Farmaceutski oblik:
  • Otopina za infuziju
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Milk
        5
        week
    • Pig
      • Meat and offal
        5
        week
    • Cattle
      • Milk
        5
        week
Kod anatomsko-terapijsko-kemijske klasifikacije (ATKvet kȏd):
  • QA12AX
Pravni status opskrbe:
Te informacije nisu dostupne za ovaj lijek.
Status odobrenja:
  • Važeće
Authorised in:
  • Poland
Available in:
  • Poland
Opis paketa:

Dodatne informacije

Entitlement type:
Pravna osnova za odobrenje proizvoda:
Nositelj odobrenja za stavljanje u promet:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Mjesta proizvodnje za izdavanje serije:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Odgovorno tijelo:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Broj autorizacije:
  • 3171
Datum promjene statusa odobrenja:
Referentna država članica:
Broj postupka:
  • PL/V/0110/001
Dotična država članica:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."